Bionpharma Discontinued
FDA Approved Drugs

Bionpharma Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 13
  • Latest Approval Date Aug 19, 2025
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
126
View
Discontinued
13
View
OTC
15
View
RX
98
View
Company Overview

Company

Bionpharma Discontinued

Country

U.S.A

Website

Visit Website

Email

admin@bionpharma.com

Social Profiles

Company Snapshot

Bionpharma Discontinued

Suite 2-4B, 600 Alexander Road, Princeton, NJ 08540

U.S.A

www.bionpharma.com/index.html admin@bionpharma.com View on Map
FDA Approved Drug Records ( 13 records )
1982
01 Jan
Discontinued Application: 80429

Drug Name

ANESTACON

Product Number

1

Dosage Form

-

Strength

2%

Approval Date

1982-01-01

80429 / 1

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

80429

Product Number

1

Dosage Form

-

Strength

2%

Approval Date

1982-01-01

Regulatory Status

Discontinued

2020
08 Apr
Discontinued Application: 210152

Drug Name

APIXABAN

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2020-04-08

210152 / 1

Active Ingredient

APIXABAN

Application Number

210152

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2020-04-08

Regulatory Status

Discontinued

2020
08 Apr
Discontinued Application: 210152

Drug Name

APIXABAN

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2020-04-08

210152 / 2

Active Ingredient

APIXABAN

Application Number

210152

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2020-04-08

Regulatory Status

Discontinued

2015
28 Jul
Discontinued Application: 90176

Drug Name

AZELASTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.137MG/SPRAY

Approval Date

2015-07-28

90176 / 1

Active Ingredient

AZELASTINE HYDROCHLORIDE

Application Number

90176

Product Number

1

Dosage Form

-

Strength

0.137MG/SPRAY

Approval Date

2015-07-28

Regulatory Status

Discontinued

2020
24 Mar
Discontinued Application: 209754

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2020-03-24

209754 / 1

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

209754

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2020-03-24

Regulatory Status

Discontinued

2020
24 Mar
Discontinued Application: 209754

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2020-03-24

209754 / 2

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

209754

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2020-03-24

Regulatory Status

Discontinued

2020
10 Dec
Discontinued Application: 209393

Drug Name

DOXYCYCLINE HYCLATE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2020-12-10

209393 / 1

Active Ingredient

DOXYCYCLINE HYCLATE

Application Number

209393

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2020-12-10

Regulatory Status

Discontinued

2020
10 Dec
Discontinued Application: 209393

Drug Name

DOXYCYCLINE HYCLATE

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-12-10

209393 / 2

Active Ingredient

DOXYCYCLINE HYCLATE

Application Number

209393

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-12-10

Regulatory Status

Discontinued

2025
23 Jun
Discontinued Application: 219153

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

40MG/5ML

Approval Date

2025-06-23

219153 / 1

Active Ingredient

FAMOTIDINE

Application Number

219153

Product Number

1

Dosage Form

-

Strength

40MG/5ML

Approval Date

2025-06-23

Regulatory Status

Discontinued

2008
29 Jul
Discontinued Application: 22152

Drug Name

STAVZOR

Product Number

1

Dosage Form

-

Strength

125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-07-29

22152 / 1

Active Ingredient

VALPROIC ACID

Application Number

22152

Product Number

1

Dosage Form

-

Strength

125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-07-29

Regulatory Status

Discontinued

2008
29 Jul
Discontinued Application: 22152

Drug Name

STAVZOR

Product Number

2

Dosage Form

-

Strength

250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-07-29

22152 / 2

Active Ingredient

VALPROIC ACID

Application Number

22152

Product Number

2

Dosage Form

-

Strength

250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-07-29

Regulatory Status

Discontinued

2008
29 Jul
Discontinued Application: 22152

Drug Name

STAVZOR

Product Number

3

Dosage Form

-

Strength

500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-07-29

22152 / 3

Active Ingredient

VALPROIC ACID

Application Number

22152

Product Number

3

Dosage Form

-

Strength

500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-07-29

Regulatory Status

Discontinued

2025
19 Aug
Discontinued Application: 219123

Drug Name

TRANEXAMIC ACID

Product Number

1

Dosage Form

-

Strength

650MG

Approval Date

2025-08-19

219123 / 1

Active Ingredient

TRANEXAMIC ACID

Application Number

219123

Product Number

1

Dosage Form

-

Strength

650MG

Approval Date

2025-08-19

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    126 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
13 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ANESTACON

Application Number

80429

Product Number

1

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Dosage Form

-

Strength

2%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit